Alnylam Pharmaceuticals (DE:DUL)
FRANKFURT:DUL
Holding DE:DUL?
Track your performance easily

Alnylam Pharma (DUL) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Alnylam Pharmaceuticals’s (DUL) Moving Averages Convergence Divergence (MACD) indicator is 0.49, suggesting Alnylam Pharmaceuticals is a Buy.
Alnylam Pharmaceuticals’s (DUL) 20-Day exponential moving average is 256.52, while Alnylam Pharmaceuticals’s (DUL) share price is €258.6, making it a Buy.
Alnylam Pharmaceuticals’s (DUL) 50-Day exponential moving average is 250.08, while Alnylam Pharmaceuticals’s (DUL) share price is €258.6, making it a Buy.

Alnylam Pharma (DUL) Pivot Points

Nov 14, 2024, 09:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
261.10
261.10
261.10
261.10
261.10
261.10
261.10
Fibonacci
261.10
261.10
261.10
261.10
261.10
261.10
261.10
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Alnylam Pharma (DUL) Moving Averages

Nov 14, 2024, 09:17 AM
Period
Simple
Exponential
MA5
254.56Buy
255.99Buy
MA10
253.61Buy
256.02Buy
MA20
262.17Sell
256.52Buy
MA50
249.43Buy
250.08Buy
MA100
241.06Buy
233.81Buy
MA200
191.57Buy
202.65Buy
Alnylam Pharmaceuticals’s (DUL) 10-Day exponential moving average is 256.02, while Alnylam Pharmaceuticals’s (DUL) share price is €258.6, making it a Buy.
Alnylam Pharmaceuticals’s (DUL) 100-Day exponential moving average is 233.81, while Alnylam Pharmaceuticals’s (DUL) share price is €258.6, making it a Buy.
Alnylam Pharmaceuticals’s (DUL) stock price is €258.6 and Alnylam Pharmaceuticals’s (DUL) 50-day simple moving average is 249.43, creating a Buy signal.
Alnylam Pharmaceuticals’s (DUL) stock price is €258.6 and Alnylam Pharmaceuticals’s (DUL) 100-day simple moving average is 241.06, creating a Buy signal.
Alnylam Pharmaceuticals’s (DUL) stock price is €258.6 and Alnylam Pharmaceuticals’s (DUL) 200-day simple moving average is 191.57, creating a Buy signal.

Alnylam Pharma (DUL) Technical Indicators

Nov 14, 2024, 09:17 AM
Name
Value
Implied Action
RSI (14)
53.03
Neutral
STOCH (9,6)
74.29
Neutral
STOCHRSI (14)
48.03
Neutral
MACD (12,26)
0.49
Buy
ADX (14)
18.78
Buy
Williams %R
-44.93
Buy
CCI (14)
-25.08
Neutral
ATR (14)
4.14
-
Ultimate Oscillator
60.42
Neutral
ROC
-4.79
Sell
Alnylam Pharmaceuticals’s (DUL) Relative Strength Index (RSI) is 53.03, creating a Neutral signal.
Alnylam Pharmaceuticals’s (DUL) Trend Strength Indicator (ADX) is 18.78, creating a Buy signal.
Alnylam Pharmaceuticals’s (DUL) Commodity Channel Index (CCI) is -25.08, creating a Neutral signal.
Alnylam Pharmaceuticals’s (DUL) Price Rate of Change (ROC) is -4.79, creating a Sell signal.

FAQ

Is DUL a Buy, Hold, or Sell?
Based on DUL’s technical indicators, DUL is a Strong Buy.
    What is DUL’s RSI (14)?
    DUL’s RSI (14) is 53.03, which suggests DUL is a Neutral.
      What is DUL’s MACD?
      DUL’s MACD is 0.49, which suggests DUL is a Buy.
        What is DUL’s 5-day moving average?
        DUL’s 5-day moving average is 254.56, which suggests DUL is a Buy.
          What is DUL’s 20-day moving average?
          DUL 20-day moving average is 262.17, which suggests DUL is a Sell.
            What is DUL’s 50-day moving average?
            DUL’s 50-day moving average is 249.43, which suggests DUL is a Buy.
              What is DUL’s 200-day moving average?
              DUL’s 200-day moving average is 191.57, which suggests DUL is a Buy.
                What is DUL’s Williams % R (14)?
                DUL’s Williams % R (14) is -44.93, which suggests DUL is a Buy.
                  What is DUL’s CCI (14)?
                  DUL’s CCI (14) is -25.08, which suggests DUL is a Neutral.
                    What is the share price of Alnylam Pharmaceuticals?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis